Industry Research Reports

Home > Reports > Pharma & Healthcare > Drugs For Travelers' Diarrhea (TD) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Drugs For Travelers' Diarrhea (TD) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030

Industry: Pharma & Healthcare

Published: 2024-01-11

Pages: 98 Pages

Report ld: 2638634

Description
Table of Contents
Table of Figures
PDF Download

Description
Table of Contents
Table of Figures
PDF Download

Description

The global market for Drugs For Travelers' Diarrhea (TD) was estimated to be worth US$ 1326 million in 2023 and is forecast to a readjusted size of US$ 1808.7 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Drugs For Travelers' Diarrhea (TD) Market Size

M= millions and B=billions

Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs For Travelers' Diarrhea (TD), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Drugs For Travelers' Diarrhea (TD) by region & country, by Type, and by Application.

The Drugs For Travelers' Diarrhea (TD) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs For Travelers' Diarrhea (TD).

Market Segmentation

Report Metric
Details
Report Title
Drugs For Travelers' Diarrhea (TD) - Global Market Share and Ranking, Overall Sales and Demand Forecast 2024-2030
Forecasted Market Size in 2030
US$ 1808.7 million
CAGR(2024-2030)
5.1%
Market Size Available for Years
2019-2030
Global Drugs For Travelers' Diarrhea (TD) Companies Covered
Johnson & Johnson, Bausch Health Companies Inc., COSMO PHARMACEUTICALS, Immuron, Valneva SE, Sun Pharmaceutical Industries Ltd., Norgine, Perrigo Company Plc, Bayer AG
Global Drugs For Travelers' Diarrhea (TD) Market, by Region
North America (U.S., Canada, Mexico)

Europe (Germany, France, UK, Italy, etc.)

Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)

South America (Brazil, etc.)

Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Drugs For Travelers' Diarrhea (TD) Market, Segment by Type
Oral Rehydration Therapy (ORS)

Antidiarrheal Agents

Antibiotics

Others
Global Drugs For Travelers' Diarrhea (TD) Market, Segment by Application
Adults

Children
Forecast Units
USD million in value
Report Coverage
Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size (valve, volume and price). This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Drugs For Travelers' Diarrhea (TD) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Sales, revenue of Drugs For Travelers' Diarrhea (TD) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Sales, revenue of Drugs For Travelers' Diarrhea (TD) in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.

Table of Contents

 1 Market Overview
    1.1 Drugs For Travelers' Diarrhea (TD) Product Introduction
    1.2 Global Drugs For Travelers' Diarrhea (TD) Market Size Forecast
        1.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030)
        1.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume (2019-2030)
        1.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Price (2019-2030)
    1.3 Drugs For Travelers' Diarrhea (TD) Market Trends & Drivers
        1.3.1 Drugs For Travelers' Diarrhea (TD) Industry Trends
        1.3.2 Drugs For Travelers' Diarrhea (TD) Market Drivers & Opportunity
        1.3.3 Drugs For Travelers' Diarrhea (TD) Market Challenges
        1.3.4 Drugs For Travelers' Diarrhea (TD) Market Restraints
    1.4 Assumptions and Limitations
    1.5 Study Objectives
    1.6 Years Considered

 2 Competitive Analysis by Company
    2.1 Global Drugs For Travelers' Diarrhea (TD) Players Revenue Ranking (2023)
    2.2 Global Drugs For Travelers' Diarrhea (TD) Revenue by Company (2019-2024)
    2.3 Global Drugs For Travelers' Diarrhea (TD) Players Sales Volume Ranking (2023)
    2.4 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Company Players (2019-2024)
    2.5 Global Drugs For Travelers' Diarrhea (TD) Average Price by Company (2019-2024)
    2.6 Key Manufacturers Drugs For Travelers' Diarrhea (TD) Manufacturing Base Distribution and Headquarters
    2.7 Key Manufacturers Drugs For Travelers' Diarrhea (TD) Product Offered
    2.8 Key Manufacturers Time to Begin Mass Production of Drugs For Travelers' Diarrhea (TD)
    2.9 Drugs For Travelers' Diarrhea (TD) Market Competitive Analysis
        2.9.1 Drugs For Travelers' Diarrhea (TD) Market Concentration Rate (2019-2024)
        2.9.2 Global 5 and 10 Largest Manufacturers by Drugs For Travelers' Diarrhea (TD) Revenue in 2023
        2.9.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs For Travelers' Diarrhea (TD) as of 2023)
    2.10 Mergers & Acquisitions, Expansion

 3 Segmentation by Type
    3.1 Introduction by Type
        3.1.1 Oral Rehydration Therapy (ORS)
        3.1.2 Antidiarrheal Agents
        3.1.3 Antibiotics
        3.1.4 Others
    3.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type
        3.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2019 VS 2023 VS 2030)
        3.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value, by Type (2019-2030)
        3.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Value, by Type (%) (2019-2030)
    3.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type
        3.3.1 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2019 VS 2023 VS 2030)
        3.3.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume, by Type (2019-2030)
        3.3.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume, by Type (%) (2019-2030)
    3.4 Global Drugs For Travelers' Diarrhea (TD) Average Price by Type (2019-2030)

 4 Segmentation by Application
    4.1 Introduction by Application
        4.1.1 Adults
        4.1.2 Children
    4.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application
        4.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2019 VS 2023 VS 2030)
        4.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value, by Application (2019-2030)
        4.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Value, by Application (%) (2019-2030)
    4.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application
        4.3.1 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2019 VS 2023 VS 2030)
        4.3.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume, by Application (2019-2030)
        4.3.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume, by Application (%) (2019-2030)
    4.4 Global Drugs For Travelers' Diarrhea (TD) Average Price by Application (2019-2030)

 5 Segmentation by Region
    5.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region
        5.1.1 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region: 2019 VS 2023 VS 2030
        5.1.2 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2019-2024)
        5.1.3 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2025-2030)
        5.1.4 Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (%), (2019-2030)
    5.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region
        5.2.1 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region: 2019 VS 2023 VS 2030
        5.2.2 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2019-2024)
        5.2.3 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2025-2030)
        5.2.4 Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (%), (2019-2030)
    5.3 Global Drugs For Travelers' Diarrhea (TD) Average Price by Region (2019-2030)
    5.4 North America
        5.4.1 North America Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        5.4.2 North America Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
    5.5 Europe
        5.5.1 Europe Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        5.5.2 Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
    5.6 Asia Pacific
        5.6.1 Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        5.6.2 Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
    5.7 South America
        5.7.1 South America Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        5.7.2 South America Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
    5.8 Middle East & Africa
        5.8.1 Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        5.8.2 Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030

 6 Segmentation by Key Countries/Regions
    6.1 Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value Growth Trends, 2019 VS 2023 VS 2030
    6.2 Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value
        6.2.1 Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        6.2.2 Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Volume, 2019-2030
    6.3 United States
        6.3.1 United States Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        6.3.2 United States Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
        6.3.3 United States Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
    6.4 Europe
        6.4.1 Europe Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        6.4.2 Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
        6.4.3 Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
    6.5 China
        6.5.1 China Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        6.5.2 China Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
        6.5.3 China Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
    6.6 Japan
        6.6.1 Japan Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        6.6.2 Japan Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
        6.6.3 Japan Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
    6.7 South Korea
        6.7.1 South Korea Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        6.7.2 South Korea Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
        6.7.3 South Korea Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
    6.8 Southeast Asia
        6.8.1 Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        6.8.2 Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
        6.8.3 Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030
    6.9 India
        6.9.1 India Drugs For Travelers' Diarrhea (TD) Sales Value, 2019-2030
        6.9.2 India Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
        6.9.3 India Drugs For Travelers' Diarrhea (TD) Sales Value by Application, 2023 VS 2030

 7 Company Profiles
    7.1 Johnson & Johnson
        7.1.1 Johnson & Johnson Company Information
        7.1.2 Johnson & Johnson Introduction and Business Overview
        7.1.3 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
        7.1.4 Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Product Offerings
        7.1.5 Johnson & Johnson Recent Development
    7.2 Bausch Health Companies Inc.
        7.2.1 Bausch Health Companies Inc. Company Information
        7.2.2 Bausch Health Companies Inc. Introduction and Business Overview
        7.2.3 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
        7.2.4 Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Product Offerings
        7.2.5 Bausch Health Companies Inc. Recent Development
    7.3 COSMO PHARMACEUTICALS
        7.3.1 COSMO PHARMACEUTICALS Company Information
        7.3.2 COSMO PHARMACEUTICALS Introduction and Business Overview
        7.3.3 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
        7.3.4 COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Product Offerings
        7.3.5 COSMO PHARMACEUTICALS Recent Development
    7.4 Immuron
        7.4.1 Immuron Company Information
        7.4.2 Immuron Introduction and Business Overview
        7.4.3 Immuron Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
        7.4.4 Immuron Drugs For Travelers' Diarrhea (TD) Product Offerings
        7.4.5 Immuron Recent Development
    7.5 Valneva SE
        7.5.1 Valneva SE Company Information
        7.5.2 Valneva SE Introduction and Business Overview
        7.5.3 Valneva SE Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
        7.5.4 Valneva SE Drugs For Travelers' Diarrhea (TD) Product Offerings
        7.5.5 Valneva SE Recent Development
    7.6 Sun Pharmaceutical Industries Ltd.
        7.6.1 Sun Pharmaceutical Industries Ltd. Company Information
        7.6.2 Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
        7.6.3 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
        7.6.4 Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Product Offerings
        7.6.5 Sun Pharmaceutical Industries Ltd. Recent Development
    7.7 Norgine
        7.7.1 Norgine Company Information
        7.7.2 Norgine Introduction and Business Overview
        7.7.3 Norgine Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
        7.7.4 Norgine Drugs For Travelers' Diarrhea (TD) Product Offerings
        7.7.5 Norgine Recent Development
    7.8 Perrigo Company Plc
        7.8.1 Perrigo Company Plc Company Information
        7.8.2 Perrigo Company Plc Introduction and Business Overview
        7.8.3 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
        7.8.4 Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Product Offerings
        7.8.5 Perrigo Company Plc Recent Development
    7.9 Bayer AG
        7.9.1 Bayer AG Company Information
        7.9.2 Bayer AG Introduction and Business Overview
        7.9.3 Bayer AG Drugs For Travelers' Diarrhea (TD) Sales, Revenue and Gross Margin (2019-2024)
        7.9.4 Bayer AG Drugs For Travelers' Diarrhea (TD) Product Offerings
        7.9.5 Bayer AG Recent Development

 8 Industry Chain Analysis
    8.1 Drugs For Travelers' Diarrhea (TD) Industrial Chain
    8.2 Drugs For Travelers' Diarrhea (TD) Upstream Analysis
        8.2.1 Key Raw Materials
        8.2.2 Raw Materials Key Suppliers
        8.2.3 Manufacturing Cost Structure
    8.3 Midstream Analysis
    8.4 Downstream Analysis (Customers Analysis)
    8.5 Sales Model and Sales Channels
        8.5.1 Drugs For Travelers' Diarrhea (TD) Sales Model
        8.5.2 Sales Channel
        8.5.3 Drugs For Travelers' Diarrhea (TD) Distributors

 9 Research Findings and Conclusion

 10 Appendix
    10.1 Research Methodology
        10.1.1 Methodology/Research Approach
        10.1.2 Data Source
    10.2 Author Details
    10.3 Disclaimer

Table of Figures

List of Tables
    Table 1. Drugs For Travelers' Diarrhea (TD) Market Trends
    Table 2. Drugs For Travelers' Diarrhea (TD) Market Drivers & Opportunity
    Table 3. Drugs For Travelers' Diarrhea (TD) Market Challenges
    Table 4. Drugs For Travelers' Diarrhea (TD) Market Restraints
    Table 5. Global Drugs For Travelers' Diarrhea (TD) Revenue by Company (2019-2024) & (US$ Million)
    Table 6. Global Drugs For Travelers' Diarrhea (TD) Revenue Market Share by Company (2019-2024)
    Table 7. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Company (2019-2024) & (K Units)
    Table 8. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Market Share by Company (2019-2024)
    Table 9. Global Market Drugs For Travelers' Diarrhea (TD) Price by Company (2019-2024) & (US$/Unit)
    Table 10. Key Manufacturers Drugs For Travelers' Diarrhea (TD) Manufacturing Base Distribution and Headquarters
    Table 11. Key Manufacturers Drugs For Travelers' Diarrhea (TD) Product Type
    Table 12. Key Manufacturers Time to Begin Mass Production of Drugs For Travelers' Diarrhea (TD)
    Table 13. Global Drugs For Travelers' Diarrhea (TD) Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 14. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Drugs For Travelers' Diarrhea (TD) as of 2023)
    Table 15. Mergers & Acquisitions, Expansion Plans
    Table 16. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
    Table 17. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2019-2024) & (US$ Million)
    Table 18. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2025-2030) & (US$ Million)
    Table 19. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Value by Type (2019-2024) & (%)
    Table 20. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Value by Type (2025-2030) & (%)
    Table 21. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type: 2019 VS 2023 VS 2030 (K Units)
    Table 22. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2019-2024) & (K Units)
    Table 23. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2025-2030) & (K Units)
    Table 24. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Volume by Type (2019-2024) & (%)
    Table 25. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Volume by Type (2025-2030) & (%)
    Table 26. Global Drugs For Travelers' Diarrhea (TD) Price by Type (2019-2024) & (US$/Unit)
    Table 27. Global Drugs For Travelers' Diarrhea (TD) Price by Type (2025-2030) & (US$/Unit)
    Table 28. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
    Table 29. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2019-2024) & (US$ Million)
    Table 30. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2025-2030) & (US$ Million)
    Table 31. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Value by Application (2019-2024) & (%)
    Table 32. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Value by Application (2025-2030) & (%)
    Table 33. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application: 2019 VS 2023 VS 2030 (K Units)
    Table 34. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2019-2024) & (K Units)
    Table 35. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2025-2030) & (K Units)
    Table 36. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Volume by Application (2019-2024) & (%)
    Table 37. Global Drugs For Travelers' Diarrhea (TD) Sales Market Share in Volume by Application (2025-2030) & (%)
    Table 38. Global Drugs For Travelers' Diarrhea (TD) Price by Application (2019-2024) & (US$/Unit)
    Table 39. Global Drugs For Travelers' Diarrhea (TD) Price by Application (2025-2030) & (US$/Unit)
    Table 40. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
    Table 41. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2019-2024) & (US$ Million)
    Table 42. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2025-2030) & (US$ Million)
    Table 43. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2019-2024) & (%)
    Table 44. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Region (2025-2030) & (%)
    Table 45. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (K Units): 2019 VS 2023 VS 2030
    Table 46. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2019-2024) & (K Units)
    Table 47. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2025-2030) & (K Units)
    Table 48. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2019-2024) & (%)
    Table 49. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Region (2025-2030) & (%)
    Table 50. Global Drugs For Travelers' Diarrhea (TD) Average Price by Region (2019-2024) & (US$/Unit)
    Table 51. Global Drugs For Travelers' Diarrhea (TD) Average Price by Region (2025-2030) & (US$/Unit)
    Table 52. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
    Table 53. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2024) & (US$ Million)
    Table 54. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value, (2025-2030) & (US$ Million)
    Table 55. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Volume, (2019-2024) & (K Units)
    Table 56. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Volume, (2025-2030) & (K Units)
    Table 57. Johnson & Johnson Company Information
    Table 58. Johnson & Johnson Introduction and Business Overview
    Table 59. Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 60. Johnson & Johnson Drugs For Travelers' Diarrhea (TD) Product Offerings
    Table 61. Johnson & Johnson Recent Development
    Table 62. Bausch Health Companies Inc. Company Information
    Table 63. Bausch Health Companies Inc. Introduction and Business Overview
    Table 64. Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 65. Bausch Health Companies Inc. Drugs For Travelers' Diarrhea (TD) Product Offerings
    Table 66. Bausch Health Companies Inc. Recent Development
    Table 67. COSMO PHARMACEUTICALS Company Information
    Table 68. COSMO PHARMACEUTICALS Introduction and Business Overview
    Table 69. COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 70. COSMO PHARMACEUTICALS Drugs For Travelers' Diarrhea (TD) Product Offerings
    Table 71. COSMO PHARMACEUTICALS Recent Development
    Table 72. Immuron Company Information
    Table 73. Immuron Introduction and Business Overview
    Table 74. Immuron Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 75. Immuron Drugs For Travelers' Diarrhea (TD) Product Offerings
    Table 76. Immuron Recent Development
    Table 77. Valneva SE Company Information
    Table 78. Valneva SE Introduction and Business Overview
    Table 79. Valneva SE Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 80. Valneva SE Drugs For Travelers' Diarrhea (TD) Product Offerings
    Table 81. Valneva SE Recent Development
    Table 82. Sun Pharmaceutical Industries Ltd. Company Information
    Table 83. Sun Pharmaceutical Industries Ltd. Introduction and Business Overview
    Table 84. Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 85. Sun Pharmaceutical Industries Ltd. Drugs For Travelers' Diarrhea (TD) Product Offerings
    Table 86. Sun Pharmaceutical Industries Ltd. Recent Development
    Table 87. Norgine Company Information
    Table 88. Norgine Introduction and Business Overview
    Table 89. Norgine Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 90. Norgine Drugs For Travelers' Diarrhea (TD) Product Offerings
    Table 91. Norgine Recent Development
    Table 92. Perrigo Company Plc Company Information
    Table 93. Perrigo Company Plc Introduction and Business Overview
    Table 94. Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 95. Perrigo Company Plc Drugs For Travelers' Diarrhea (TD) Product Offerings
    Table 96. Perrigo Company Plc Recent Development
    Table 97. Bayer AG Company Information
    Table 98. Bayer AG Introduction and Business Overview
    Table 99. Bayer AG Drugs For Travelers' Diarrhea (TD) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2019-2024)
    Table 100. Bayer AG Drugs For Travelers' Diarrhea (TD) Product Offerings
    Table 101. Bayer AG Recent Development
    Table 102. Key Raw Materials Lists
    Table 103. Raw Materials Key Suppliers Lists
    Table 104. Drugs For Travelers' Diarrhea (TD) Downstream Customers
    Table 105. Drugs For Travelers' Diarrhea (TD) Distributors List
    Table 106. Research Programs/Design for This Report
    Table 107. Key Data Information from Secondary Sources
    Table 108. Key Data Information from Primary Sources
List of Figures
    Figure 1. Drugs For Travelers' Diarrhea (TD) Product Picture
    Figure 2. Global Drugs For Travelers' Diarrhea (TD) Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
    Figure 3. Global Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
    Figure 4. Global Drugs For Travelers' Diarrhea (TD) Sales Volume (2019-2030) & (K Units)
    Figure 5. Global Drugs For Travelers' Diarrhea (TD) Sales Price (2019-2030) & (US$/Unit)
    Figure 6. Drugs For Travelers' Diarrhea (TD) Report Years Considered
    Figure 7. Global Drugs For Travelers' Diarrhea (TD) Players Revenue Ranking (2023) & (US$ Million)
    Figure 8. Global Drugs For Travelers' Diarrhea (TD) Players Sales Volume Ranking (2023) & (K Units)
    Figure 9. The 5 and 10 Largest Manufacturers in the World: Market Share by Drugs For Travelers' Diarrhea (TD) Revenue in 2023
    Figure 10. Drugs For Travelers' Diarrhea (TD) Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
    Figure 11. Oral Rehydration Therapy (ORS) Picture
    Figure 12. Antidiarrheal Agents Picture
    Figure 13. Antibiotics Picture
    Figure 14. Others Picture
    Figure 15. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 16. Global Drugs For Travelers' Diarrhea (TD) Sales Value Market Share by Type, 2023 & 2030
    Figure 17. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Type (2019 VS 2023 VS 2030) & (K Units)
    Figure 18. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Market Share by Type, 2023 & 2030
    Figure 19. Global Drugs For Travelers' Diarrhea (TD) Price by Type (2019-2030) & (US$/Unit)
    Figure 20. Product Picture of Adults
    Figure 21. Product Picture of Children
    Figure 22. Global Drugs For Travelers' Diarrhea (TD) Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
    Figure 23. Global Drugs For Travelers' Diarrhea (TD) Sales Value Market Share by Application, 2023 & 2030
    Figure 24. Global Drugs For Travelers' Diarrhea (TD) Sales Volume by Application (2019 VS 2023 VS 2030) & (K Units)
    Figure 25. Global Drugs For Travelers' Diarrhea (TD) Sales Volume Market Share by Application, 2023 & 2030
    Figure 26. Global Drugs For Travelers' Diarrhea (TD) Price by Application (2019-2030) & (US$/Unit)
    Figure 27. North America Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
    Figure 28. North America Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
    Figure 29. Europe Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
    Figure 30. Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
    Figure 31. Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
    Figure 32. Asia Pacific Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
    Figure 33. South America Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
    Figure 34. South America Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
    Figure 35. Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value (2019-2030) & (US$ Million)
    Figure 36. Middle East & Africa Drugs For Travelers' Diarrhea (TD) Sales Value by Country (%), 2023 VS 2030
    Figure 37. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Value (%), (2019-2030)
    Figure 38. Key Countries/Regions Drugs For Travelers' Diarrhea (TD) Sales Volume (%), (2019-2030)
    Figure 39. United States Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
    Figure 40. United States Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
    Figure 41. United States Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
    Figure 42. Europe Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
    Figure 43. Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
    Figure 44. Europe Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
    Figure 45. China Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
    Figure 46. China Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
    Figure 47. China Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
    Figure 48. Japan Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
    Figure 49. Japan Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
    Figure 50. Japan Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
    Figure 51. South Korea Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
    Figure 52. South Korea Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
    Figure 53. South Korea Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
    Figure 54. Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
    Figure 55. Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
    Figure 56. Southeast Asia Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
    Figure 57. India Drugs For Travelers' Diarrhea (TD) Sales Value, (2019-2030) & (US$ Million)
    Figure 58. India Drugs For Travelers' Diarrhea (TD) Sales Value by Type (%), 2023 VS 2030
    Figure 59. India Drugs For Travelers' Diarrhea (TD) Sales Value by Application (%), 2023 VS 2030
    Figure 60. Drugs For Travelers' Diarrhea (TD) Industrial Chain
    Figure 61. Drugs For Travelers' Diarrhea (TD) Manufacturing Cost Structure
    Figure 62. Channels of Distribution (Direct Sales, and Distribution)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed

Description

The global market for Drugs For Travelers' Diarrhea (TD) was estimated to be worth US$ 1326 million in 2023 and is forecast to a readjusted size of US$ 1808.7 million by 2030 with a CAGR of 5.1% during the forecast period 2024-2030
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope
This report aims to provide a comprehensive presentation of the global market for Drugs For Travelers' Diarrhea (TD), focusing on the total sales volume, sales revenue, price, key companies market share and ranking, together with an analysis of Drugs For Travelers' Diarrhea (TD) by region & country, by Type, and by Application.

The Drugs For Travelers' Diarrhea (TD) market size, estimations, and forecasts are provided in terms of sales volume (K Units) and sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drugs For Travelers' Diarrhea (TD).

Market Segmentation